Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA approves first drug to treat tardive dyskinesia
The U.
Medivir Announces Positive Data From the Phase II Study of Remetinostat in Patients With Early-stage Cutaneous T-cell Lymphoma
STOCKHOLM, April 7, 2016 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm.
BerGenBio completes IPO, raising $49M for cancer trials
BerGenBio has completed (sub.
Phase III Study Shows Roche's Alecensa Improves PFS over Crizotinib in ALK-Positive NSCLC
Roche said a second Phase III study has shown that non-small-cell lung cancer (NSCLC) patients treated with its oral anaplastic lymphoma kinase (ALK) inhibitor Alecensa® (alectini...
PeptiDream and J&J ink billion-dollar drug discovery deal
PeptiDream has once again turned small molecules into big business, signing a new discovery agreement with Johnson & Johnson’s Janssen Pharmaceutical Companies that could be worth up to $1.
Cystic fibrosis market will rocket to $7.6 billion by 2025 as drugs improve
The cystic fibrosis space across the seven major markets of the US, France, Germany, Italy, Spain, the UK, and Canada, is set to more than triple from $2.
Greek official: 'Thousands' of people implicated in Novartis bribery probe
The public drama surrounding an investigation into alleged bribes by Novartis to sell more drugs in Greece entered a new act today as the country’s justice minister told a state news agency the drug...
Stada Accepts $5.6 Billion Takeover Offer From Bain, Cinven
Stada Arzneimittel AG agreed to sell itself to Bain Capital and Cinven for 5.
Jazz deal strengthens Hikma’s hand on Xyrem generic in USA
Jordanian drugmaker Hikma Pharmaceuticals (LSE.
Gilead discloses China manufacturing plans on a recruitment website
Gilead Sciences hired a former Roche exec last fall to help it launch its hep C and hep B drugs in China, a market with big potential.
120 million Indians to be diabetic in next 20 years
New Delhi.
Allergan to move into Phase III trials with depression drug that’s raising eyebrows
Botox (onabotulinumtoxinA), a treatment which made its name for its aesthetic potential in reducing facial wrinkles, is to be taken into Phase III trials in major depressive disorder (MDD&...
545
546
547
548
549
550
551
552
553
